Citations 1
A phase 1 safety study of SBP-101, a polyamine metabolic inhibitor, for pancreatic ductal adenocarcinoma (PDA).
Kotasek, Dusan , Borazanci, Erkut , Smith, Sheri , Shah, Ajit , Walker, Michael J. , Cullen, Michael, Gagnon, Suzanne , Borazanci, Erkut , Tebbutt, Niall C. , Borad, Mitesh J. , Cullen, Michael T.
Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: e16231-e16231
